cell biology – Page 13 – Retraction Watch

“Apparently, the bureaucracy at Elsevier is the most cumbersome thing in the world:” Journal editor

We recently came across a paper in Biochemical and Biophysical Research Communications, an Elsevier title, that had been temporarily removed without explanation. While we see a fair number of such opaque notices from Elsevier — and have written about why we think they’re a bad idea — we took interest in this one because the last author, Toren Finkel of the NIH, was the corresponding author of a Nature paper retracted earlier this year. (He also had two corrections on one Science paper, both of which are paywalled.)

What we learned suggests the withdrawal was completely unrelated to the Nature retraction, but also reveals a journal editor’s exasperation.

Continue reading “Apparently, the bureaucracy at Elsevier is the most cumbersome thing in the world:” Journal editor

Update: Lab head shares “painful” process that led to Molecular Cell retraction

Last month, we published a guest post by Jean Hazel Mendoza about the retraction of a Molecular Cell paper for sampling errors, flawed analysis, and and miscalculation.

Mendoza heard back from Jean-François Allemand, the head of one of the labs involved. Allemand tells Retraction Watch by email that when his group tried to repeat the experiment, they suspected of “missing” or “averaging” of data points in the retracted paper: Continue reading Update: Lab head shares “painful” process that led to Molecular Cell retraction

UT-Southwestern cancer researchers up to 8 retractions

A group at the University of Texas Southwestern led by Adi F. Gazdar that found evidence of inappropriate image manipulation in a number of their papers has retracted its seventh and eighth studies.

Here’s the notice for 2005’s “Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection,” in Oncogene: Continue reading UT-Southwestern cancer researchers up to 8 retractions

Former University of Utah researchers, one guilty of “reckless disregard,” have another paper retracted

A pair of University of Utah researchers who both left their posts last year following an investigation into problems with their work have had another paper retracted from Cell Metabolism.

The investigation found “reckless disregard” in papers in which Ivana De Domenico was first author. She left the university at the end of June 2013, and and her lab head, Jerry Kaplan, retired at the same time.

Here’s the notice for 2008’s “The Hepcidin-Binding Site on Ferroportin Is Evolutionarily Conserved:” Continue reading Former University of Utah researchers, one guilty of “reckless disregard,” have another paper retracted

Cancer researcher who threatened to sue Retraction Watch corrects another paper

Bharat Aggarwal, the MD Anderson researcher who has threatened to sue Retraction Watch for writing about issues in his papers, has corrected another study.

Here’s the notice for “Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors:” Continue reading Cancer researcher who threatened to sue Retraction Watch corrects another paper

De-coli: Plagiarism leads to retraction of highly cited recombinant protein paper

The authors of a 2005 article on E. coli in Applied Microbiology and Biotechnology have lost the paper because they recombined it from previous work.

The article, titled “Strategies for efficient production of heterologous proteins in Escherichia coli,” came from a pair of biochemical engineers from the Indian Institute of Technology-Delhi, in New Delhi, India.

According to the abstract: Continue reading De-coli: Plagiarism leads to retraction of highly cited recombinant protein paper

Sampling error, flawed analysis, and miscalculation trigger Molecular Cell retraction

Guest post by Jean Hazel Mendoza

A group of researchers from France has retracted a 2013 paper from Molecular Cell after realizing that their analyses of microscopy images were flawed.

Here’s the notice for “RecA-Promoted, RecFOR-Independent Progressive Disassembly of Replisomes Stalled by Helicase Inactivation:” Continue reading Sampling error, flawed analysis, and miscalculation trigger Molecular Cell retraction

Shigeaki Kato up to 25 retractions

Shigeaki Kato, who resigned from the University of Tokyo in 2012 after being found to have inappropriately manipulated dozens of images, has two more retractions, both in Molecular Cell.

Here’s the notice for 2002’s “Nuclear Receptor Function Requires a TFTC-Type Histone Acetyl Transferase Complex:” Continue reading Shigeaki Kato up to 25 retractions

Retraction appears for former federal contractor who faked data

In December, we reported on the case of Timothy Sheehy, a former government contractor who was found to have faked results. ORI found that Sheehy

fabricated the quantitative and qualitative data for RNA and DNA purportedly extracted from 900 formalin-fixed, paraffin-embedded (FFPE) colorectal tissue samples presented in Table 1 of the CEBP paper and falsely reported successful methodology to simultaneously recover nucleic acids from FFPE tissue specimens, when neither the extractions nor analyses of the FFPE samples were done. Thus, the main conclusions of the CEBP paper are based on fabricated data and are false.

Sheehy agreed to ask that one of his papers be retracted. The retraction notice has appeared: Continue reading Retraction appears for former federal contractor who faked data